Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-08-17FDA Approved: FENOFIBRATE — Original Application (Leading Pharma, LLC)
FDA approved Leading Pharma, LLC's original Abbreviated New Drug Application for fenofibrate, enabling marketing of a generic fenofibrate pr…
-
FDA approval · 2018-07-20FDA Approved: FENOFIBRATE — Original Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s generic fenofibrate (FENOFIBRATE) under an Original Abbreviated New Drug Application.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia [Phase 1, Phase 2]
Clinical trial update on two herbal dietary supplements evaluating lipid metabolism in moderate hypercholesterolemia and hypertriglyceridemi…
-
FDA approval · 2018-06-26FDA Approved: FENOFIBRATE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Fenofibrate's original application from Torrent Pharmaceuticals Limited under ANDA210782, making a generic option available for…
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis. [Phase 4]
A Phase 4 clinical trial evaluating intensive insulin therapy for pancreatitis associated with severe/moderate hypertriglyceridemia; current…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides [Phase 1]
Phase 1 study assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of APOCIII-LRx in healthy volunteers with elevated trig…
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for fenofibrate submitted by Lupin Pharmaceuticals, Inc. The notice indicates an updated approval fo…
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.,)
FDA approved a supplemental application for fenofibrate filed by Cipla USA Inc. under ANDA207378.
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC, approving a generic fenofibrate product.
-
FDA approval · 2018-05-18FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lipofen (fenofibrate) filed by ANI Pharmaceuticals, Inc.
-
FDA label_change · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for fenofibrate from Glenmark Pharmaceuticals Inc., USA, resulting in changes to the drug’s labe…
-
FDA approval · 2018-05-18FDA Approved: FENOFIBRATE — Supplemental Application (Bostal LLC)
FDA approved a supplemental application for Fenofibrate submitted by Bostal LLC under ANDA 207805. The approval confirms the continued appro…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Metabolic Effects of Egg Protein and Unsaturated Fat Intakes in Subjects With Hypertriglyceridemia [NA]
This clinical trial update reports the completed study evaluating the metabolic effects of egg protein and unsaturated fat intake in adults …
-
FDA approval · 2018-04-30FDA Approved: FENOFIBRATE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' generic fenofibrate under an Original Application (ANDA 209504).
-
FDA approval · 2018-04-25FDA Approved: LOPID — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Lopid (gemfibrozil) submitted by Parke-Davis Div of Pfizer Inc.
-
FDA approval · 2018-04-20FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels [NA]
A completed clinical trial comparing phytosterol esters of omega-3 (Vayarol) to omega-3 fatty acid ethyl esters for reducing triglyceride le…
-
FDA approval · 2018-03-19FDA Approved: FENOFIBRATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's fenofibrate generic under an original application (ANDA). This represents the approval of a fen…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides [NA]
This clinical trial update reports on the vascular and lipid effects of omega-3 fatty acids in people with moderately elevated triglycerides…
-
FDA approval · 2018-02-09FDA Approved: FENOFIBRATE — Original Application (AvKARE)
FDA approved AvKARE's generic fenofibrate under an Original Application (ANDA 209951).
-
FDA approval · 2018-02-01FDA Approved: NIACIN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for NIACIN, a generic niacin product intended to treat dyslipidemia and related lipid …
-
FDA approval · 2017-12-19FDA Approved: FENOFIBRATE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' original application for fenofibrate, authorizing the marketing of a generic fenofibrate product.
-
CLINICAL_TRIALS research · 2017-11-17Clinical Trial Update: Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis [Phase 4]
A Phase 4 clinical trial investigates whether intravenous insulin plus plasma exchange can reduce triglyceride levels in hypertriglyceridemi…
-
FDA approval · 2017-11-16FDA Approved: FENOFIBRATE — Original Application (Bostal LLC)
FDA approved fenofibrate from Bostal LLC through an original application (ANDA 207805).
-
FDA approval · 2017-10-02FDA Approved: GEMFIBROZIL — Supplemental Application (Exelan Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Gemfibrozil submitted by Exelan Pharmaceuticals, Inc.